Upgrade to SI Premium - Free Trial

Tandem Diabetes Care (TNDM) PT Lowered to $13 at Wells Fargo

August 7, 2025 7:52 AM
Wells Fargo analyst Lawrence Biegelsen lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $13.00 (from $20.00) while maintaining a Equal Weight rating.

Categories

Analyst PT Change

Next Articles